Fig. 1

The cumulative incidence of developing (a) a glioma and meningioma by interval from 5-year survival separately among CNS, leukaemia, and other cancer survivors, (b) a glioma by attained age among CNS and leukaemia survivors stratified by whether received cranial radiotherapy treatment or not, and (c) a meningioma by attained age among CNS and leukaemia survivors stratified by whether received cranial radiotherapy treatment or not.